Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Mol Cancer Res. 2013 Oct 23;11(12):10.1158/1541-7786.MCR-13-0294. doi: 10.1158/1541-7786.MCR-13-0294

Table 1. Bone marrow progenitor colony formation and chimerism in transplant recipients.

Recipient
mouse#
Colony #/105 BM cells
Chimerism (+3STE)(c)
No
cytokine
+3STE(b) % Donor
chimerism
Recipient
CFU# /105
Donor
CFU# /105
BRAFV600E BMT(a)
103 0 85 6.7 79.3 5.7
106 9 92.5 6.7 86.3 6.2
114 31 42.5 53.3 19.8 22.7
118 15 117.5 0 117.5 0
122 9 80 15.4 67.7 12.3
127 33.5 72.5 93.3 4.8 67.7
Average 16.3 81.7 29.2 62.6 19.1
Control BMT (a)
116 0 165 46.7 88 77
124 0 190 26.7 139.3 50.7
128 0 225 53.3 105 120
Average 0 193.3 42.2 110.8 82.6
(a)

2×106 bone marrow nucleated cells from BRAFV600E or control mice 3 weeks after poly I:C injection were injected into each sublethally (5 Gy) irradiated Rag2−/−γc−/− recipient.

(b)

10ng/ml IL-3, 50ng/ml SCF, 100ng/ml TPO and 4U/ml EPO were added in “+3STE” cultures.

(c)

Donor chimerism was determined by Braf genotyping of randomly plucked individual colonies developed in “+3STE” cultures, and CFU# of donor or recipient origin was calculated by multiplying total colony numbers by the %chimerism.